Overexpression of the Gastrin-Releasing Peptide in Cutaneous Nerve Fibers and Its Receptor in the Spinal Cord in Primates with Chronic Itch  by Nattkemper, Leigh A. et al.
Sweden and 4Dermatology Unit, Department of
Medicine Solna, Karolinska University Hospital,
Stockholm, Sweden
E-mail: cecilia.bivik@liu.se
5These authors contributed equally to this work.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online
version of the paper at http://www.nature.com/jid
REFERENCES
Akhabir L, Sandford A (2010) Genetics of interleu-
kin 1 receptor-like 1 in immune and inflam-
matory diseases. Curr Genomics 11:591–606
Bieber T (2008) Atopic dermatitis. N Engl J Med
358:1483–94
Bradley M, Kockum I, Soderhall C et al. (2000)
Characterization by phenotype of families
with atopic dermatitis. Acta Derm Venereol
80:106–10
Hirota T, Takahashi A, Kubo M et al. (2012)
Genome-wide association study identifies
eight new susceptibility loci for atopic derma-
titis in the Japanese population. Nat Genet
44:1222–6
Hitomi Y, Ebisawa M, Tomikawa M et al. (2009)
Associations of functional NLRP3 polymorph-
isms with susceptibility to food-induced
anaphylaxis and aspirin-induced asthma.
J Allergy Clin Immunol 124:779–85 e776
Homey B (2006) [After TH1/TH2 now comes
Treg/TH17: significance of T helper cells in
immune response organization]. Hautarzt 57:
730–2
Jin Y, Birlea SA, Fain PR et al. (2007a) Genetic
variations in NALP1 are associated with gen-
eralized vitiligo in a Romanian population.
J Invest Dermatol 127:2558–62
Jin Y, Mailloux CM, Gowan K et al. (2007b)
NALP1 in vitiligo-associated multiple
autoimmune disease. N Engl J Med 356:
1216–25
Kabesch M, Peters W, Carr D et al. (2003)
Association between polymorphisms in cas-
pase recruitment domain containing protein
15 and allergy in two German populations.
J Allergy Clin Immunol 111:813–7
Kastbom A, Johansson M, Verma D et al. (2010)
CARD8 p.C10X polymorphism is associated
with inflammatory activity in early rheumatoid
arthritis. Ann Rheum Dis 69:723–6
Kastbom A, Verma D, Eriksson P et al. (2008)
Genetic variation in proteins of the cryopyrin
inflammasome influences susceptibility and
severity of rheumatoid arthritis (the Swedish
TIRA project). Rheumatology (Oxford) 47:
415–7
Li H, Willingham SB, Ting JP et al. (2008) Cutting
edge: inflammasome activation by alum and
alum’s adjuvant effect are mediated by
NLRP3. J Immunol 181:17–21
Novak N, Simon D (2011) Atopic dermatitis - from
new pathophysiologic insights to individua-
lized therapy. Allergy 66:830–9
Paternoster L, Standl M, Chen CM et al. (2012)
Meta-analysis of genome-wide asso-
ciation studies identifies three new risk
loci for atopic dermatitis. Nat Genet 44:
187–92
Roberts RL, Topless RK, Phipps-Green AJ et al.
(2010) Evidence of interaction of CARD8
rs2043211 with NALP3 rs35829419 in
Crohn’s disease. Genes Immun 11:351–6
Savinko T, Matikainen S, Saarialho-Kere U et al.
(2012) IL-33 and ST2 in atopic dermatitis:
expression profiles and modulation by
triggering factors. J Invest Dermatol 132:
1392–400
Schoultz I, Verma D, Halfvarsson J et al. (2009)
Combined polymorphisms in genes encoding
the inflammasome components NALP3 and
CARD8 confer susceptibility to Crohn’s dis-
ease in Swedish men. Am J Gastroenterol
104:1180–8
Verma D, Bivik C, Farahani E et al. (2012)
Inflammasome polymorphisms confer sus-
ceptibility to sporadic malignant melanoma.
Pigment Cell Melanoma Res 25:506–13
Villani AC, Lemire M, Fortin G et al. (2009)
Common variants in the NLRP3 region con-
tribute to Crohn’s disease susceptibility. Nat
Genet 41:71–6
Overexpression of the Gastrin-Releasing Peptide in
Cutaneous Nerve Fibers and Its Receptor in the Spinal Cord
in Primates with Chronic Itch
Journal of Investigative Dermatology (2013) 133, 2489–2492; doi:10.1038/jid.2013.166; published online 9 May 2013
TO THE EDITOR
Chronic pruritus affects millions of
patients worldwide and has a significant
impact on quality of life similar to
that of chronic pain (Sta¨nder et al.,
2007; Kini et al., 2011). Significant
advances have been made in the past
5 years to elucidate the molecular
pathways of acute itch (Sun and Chen,
2007; Liu et al., 2009). However,
experimental approaches investigating
the pathogenesis of pruritus and the
ability to test novel therapeutic agents
are largely limited to rodent models.
Although these models offer some
advantages, their translational potential
to human disease remains to be establi-
shed (Jeffry et al., 2011; Seok et al.,
2013). Furthermore, most animal models
focus on acute itch, which displays sig-
nificant pathophysiological differences
in comparison with chronic itch
(Yosipovitch et al., 2007). Therefore,
there is an unmet need for better
animal models for chronic itch research.
Recently, gastrin-releasing peptide
(GRP) and its receptor (GRPR) were
discovered to have a key role in itch
transmission, but not in nociception
(Sun and Chen, 2007). GRP was found
in a subset of unmyelinated dorsal root
ganglion neurons, whereas GRPR was
expressed in lamina I of the dorsal horn
of the spinal cord in mice. In the skin,
GRP is present in primary afferent nerve
fibers and is found to be increased in
mice with chronic dermatitis (Tominaga
et al., 2009). The GRP/GRPR signaling
pathway is considered to be the first
molecular pathway specific to itch
transmission, but there is no evidence
that this pathway has an analogous role
in primates or humans.
We identified a subgroup of adult
female Cynomolgus macaques (Macaca
fascicularis) suffering from idiopathic
chronic itch and observed theirAccepted article preview online 4 April 2013; published online 9 May 2013
Abbreviations: GRP, gastrin-releasing peptide; GRPR, gastrin-releasing peptide receptor; PGP9.5, product
gene protein 9.5
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scratching behaviors twice every week
for 10 minutes for 4 years, using a focal
observation technique (Altmann, 1974).
The population pattern of GRP and
GRPR expression in the skin and spinal
cord, respectively, were assessed in a
blinded manner. The expression of
GRP and GRPR was quantified by
immunohistochemistry and analyzed
with a one-way analysis of variance
and Bonferroni post hoc test, whereas
an unpaired t-test was used to compare
the amount of product gene protein
9.5-positive (PGP9.5þ ) nerve fibers
between groups. The scratching behav-
ior of each animal was then analyzed
for potential correlations with GRP and
GRPR expression levels using a two-
tailed Spearman’s correlation test and
linear regression.
The frequency (number of scratching
episodes per hour) and duration (percent
time of scratching during focal observa-
tion) of scratching were recorded over
4 years, totaling up to 68 hours of obser-
vation per animal. The animals were
killed, and histological sections from six
randomly selected animals with differ-
ent itch severities were collected. For
each primate, the total count of nerve
fibers expressing GRP in lichenified
(chronically damaged skin lesion) and
nonlichenified skin from thoracic der-
matomes was correlated with itch
severity. Skin cryosections (20mm thick-
ness) were double stained with antibo-
dies for GRP (Immunostar, Hudson, WI)
and the neuronal marker Product Gene
Protein 9.5 (PGP9.5; Neuromics, Edina,
MN) to examine the amount of coloca-
lization at the dermal–epidermal junc-
tion. Although fibers were found in
both the epidermis and dermis, they
were mainly present in the dermal–
epidermal junction, and thus all
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Figure 1. Immunohistochemical staining of gastrin-releasing peptide–positive (GRPþ ) nerve fibers in the skin of primates with chronic itch. (a) Double labeling
of product gene protein 9.5 (PGP9.5; green) and GRP (red) in lichenified skin of primates representing mild, moderate, and severe itch intensities. Primates with
higher scratching severity showed an increase of colocalization (yellow; arrowhead) of GRP in PGP9.5þ fibers at the dermal–epidermal junction compared with
primates with lower scratching severity (not colocalized; arrow). The border between the epidermis and the dermis is indicated with a dashed line (- -).
Bars¼ 56mm. The mean percentage of double-labeled GRPþ /PGP9.5þ fibers at the dermal–epidermal junction in lichenified skin but not in nonlichenified skin
significantly correlated with (b) the frequency of scratching and (c) the percent time spent scratching. (d) The number of PGP9.5þ nerve fibers does not change
between itch severities, (e) whereas the expression of GRP significantly increases with high itch severity when compared with mild/moderate severity in lichenified
skin (n¼3 per group; *Po0.05).
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quantification was focused on this area.
The population of GRPR-expressing
cells in the dorsal horn of the thoracic
spinal cord of the same animals was
also analyzed for a potential correlation
to itch intensity by staining the spinal
cord cryosections with the GRPR anti-
body (MBL International, Woburn, MA).
For a detailed methods section, see
Supplementary Information.
Primates that exhibited a compara-
tively higher severity of itching
consistently displayed an increased per-
centage of GRP-expressing nerve fibers
at the dermal–epidermal junction of
lichenified skin (P¼ 0.03; Figure 1a
and e). The mean percentage of
GRPþ /PGP9.5þ fibers was 4.8-fold
higher in primates exhibiting the highest
itch intensity than in primates with
the lowest intensity. The frequency
(Figure 1b) and duration (Figure 1c) of
scratching were significantly correlated
with the percentage of GRP in licheni-
fied skin (r¼0.94, P¼0.02; for both
frequency and duration), but not in
nonlichenified skin (r¼0.77, P¼0.10;
for both frequency and duration). The
innervation pattern of PGP9.5þ fibers in
the skin showed no significant differ-
ence of fibers in animals with severe
itch compared with those with mild/
moderate itch (Figure 1d).
In addition, an increased number of
GRPR-expressing cells was observed in
the dorsal horn of the spinal cord of
primates exhibiting a higher itch severity
compared with animals with lower itch
severity (P¼0.002; Figure 2a and d).
The frequency (Figure 2b) and duration
(Figure 2c) of scratching were also found
to be significantly correlated with the
expression of GRPR in the superficial
lamina I and II (r¼0.94, P¼0.02;
for both frequency and duration), but
only trended toward significance in the
deep lamina III–V (r¼ 0.83, P¼0.06;
for both frequency and duration) of the
dorsal horn of the thoracic spinal
cord. The number of GRPþ fibers in
lichenified skin also significantly corre-
lated to the amount of staining of GRPR
in the superficial (r¼0.94, P¼ 0.01)
and deep (r¼0.89, P¼0.03) lamina of
the dorsal horn of each primate
(Figure 2e).
GRPR and its ligand GRP are highly
expressed in the spinal cord and skin
of primates with chronic itch, which
to our knowledge is previously
unreported. It is consistent with pre-
vious findings in nonchronic itch
mice models (Sun and Chen, 2007;
Sun et al., 2009; Andoh et al., 2011).
Therefore, the GRP/GRPR system
is a promising drug target for the
treatment of chronic pruritus in
humans. Furthermore, this subset
of female Cynomolgus macaques
offers a novel model of itch that
could better represent chronic itch
in humans. This would allow for
long-term follow-up studies assessing
other mediators involved in chronic
itch.
All animal experiments were
approved by the Wake Forest University
Animal Care and Use Committee.
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Figure 2. Immunohistochemical staining of gastrin-releasing peptide receptor–positive (GRPRþ ) cells in the dorsal horn of primates with chronic itch.
(a) Labeling of GRPRþ (red) cells in the dorsal horn of the spinal cord of primates representing mild, moderate, and severe itch severities. A significant increase of
GRPRþ cells was found in the superficial lamina but not in the deep lamina of primates exhibiting severe scratching. Superficial and deep lamina are separated
with a dashed line (- -), and the dorsal horn surface is indicated with a solid line ( ). Bars¼ 56mm. The number of labeled GRPRþ cells in the superficial
lamina of the dorsal horn correlate with (b) the frequency of scratching and (c) the percent time spent scratching. (d) The number of GRPRþ neurons significantly
increases with severe itch intensity compared with mild/moderate intensity in superficial lamina (n¼ 3 per group; *Po0.05). (e) The percentage of GRPþ
fibers in lichenified skin significantly correlated to the amount of GRPRþ cells in the dorsal horn for each primate.
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